Modus Advisors LLC Purchases New Stake in Amgen Inc. (NASDAQ:AMGN)

Modus Advisors LLC bought a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 6,660 shares of the medical research company’s stock, valued at approximately $1,894,000. Several other hedge funds also recently bought and sold […]

Leave a Reply

Your email address will not be published.

Previous post Dimensional World ex U.S. Core Equity 2 ETF (NYSEARCA:DFAX) Shares Sold by Peirce Capital Management LLC
Next post Ballot questions continue march toward November after clearing latest signature hurdle